Immunotherapeutic approaches for Alzheimer’s disease: Exploring active and passive vaccine progress

2024/05/21 by Priyanshu Bhadane, Krishnashish Roul, Sateesh Belemkar +1 · 9 citations
Medicine · Neuroscience · #Alzheimer's disease research and treatments #Tryptophan and brain disorders #Neuroinflammation and Neurodegeneration Mechanisms

paper · doi:10.1016/j.brainres.2024.149018

Citations

• Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

Cited by

• Functional Relationships between L1CAM, LC3, ATG12, and Aβ. [europepmc]
• Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease. [europepmc]
• Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases. [europepmc]
• Adaptive immunity in the neuroinflammation of Alzheimer's disease. [europepmc]
• Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology. [europepmc]
• One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques. [europepmc]
• Alzheimer Syndrome or Age-Related Dementia-History, Therapy and Prevention. [europepmc]
• Adaptive Immunity and Alzheimer's Disease: Dual Roles in Neurodegeneration and Neuroprotection with Therapeutic Implications. [europepmc]
• Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment. [europepmc]